Skip to main content
. 2020 Sep 10;15(4):567–574. doi: 10.1093/ecco-jcc/jjaa184

Figure 3.

Figure 3.

Cumulative risk of clinical relapse in patients with UC, treated to target of clinical remission, who achieve persistent symptomatic and endoscopic remission with either [green] complete endoscopic remission over two consecutive endoscopies [MES 0/MES 0] or [red] mild ongoing endoscopic activity on either or both endoscopic assessments [MES 1/0, MES 0/1, or MES 1/1]. UC, ulcerative colitis; MES, Mayo Endoscopy score.